Works matching Review committees

Results: 5000
    1
    2
    3
    4
    5

    Scientific Review Committees as part of institutional review of human participant research: Initial implementation at institutions with Clinical and Translational Science Awards.

    Published in:
    Journal of Clinical & Translational Science, 2020, v. 4, n. 2, p. 115, doi. 10.1017/cts.2019.439
    By:
    • Selker, Harry P.;
    • Welch, Lisa C.;
    • Patchen-Fowler, Elizabeth;
    • Breeze, Janis L.;
    • Terrin, Norma;
    • Parajulee, Anshu;
    • LeClair, Amy;
    • Naeim, Arash;
    • Marnocha, Rebecca;
    • Morelli Novak, Julie;
    • Caldwell, Christine Sego;
    • Cola, Philip A.;
    • Croker, Jennifer A.;
    • Cifu, David X.;
    • Williams, Kirsten M.;
    • Snyder, Denise C.;
    • Kitterman, Darlene
    Publication type:
    Article
    6
    7

    CTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC Processes.

    Published in:
    CTS: Clinical & Translational Science, 2015, v. 8, n. 6, p. 623, doi. 10.1111/cts.12306
    By:
    • Selker, Harry P.;
    • Buse, John B.;
    • Califf, Robert M.;
    • Carter, Robert;
    • Cooper, Dan M.;
    • Davis, Jonathan;
    • Ford, Daniel E.;
    • Galassetti, Pietro;
    • Guay‐Woodford, Lisa;
    • Huggins, Gordon S.;
    • Kasper, Amanda;
    • Kieburtz, Karl;
    • Kirby, Aaron;
    • Klein, Andreas K.;
    • Kline, Joel;
    • O’ Neill, Robert T.;
    • Rape, Marie;
    • Reichgott, Douglas J.;
    • Rojevsky, Svetlana;
    • Rosenthal, Gary E.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"

    Published in:
    Current Oncology, 2023, v. 30, n. 5, p. 5050, doi. 10.3390/curroncol30050381
    By:
    • Rayson, Daniel;
    • Gandhi, Sonal;
    • Joy, Anil A.;
    • Brezden-Masley, Christine;
    • Gelmon, Karen A.;
    • Sehdev, Sandeep;
    • Cescon, David;
    • Chia, Stephen
    Publication type:
    Article
    45
    46
    47

    Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.

    Published in:
    Neuroendocrinology, 2021, v. 111, n. 4, p. 320, doi. 10.1159/000506743
    By:
    • Kai, Kentaro;
    • Nasu, Kaei;
    • Nishida, Haruto;
    • Daa, Tsutomu;
    • Shikama, Ayumi;
    • Shiozaki, Takaya;
    • Kurakazu, Masamitsu;
    • Yano, Mitsutake;
    • Imamura, Yuko;
    • Tokunaga, Hideki;
    • Tasaki, Kazuto;
    • Iida, Yasushi;
    • Yamada, Yuki;
    • Morisawa, Hiroyuki;
    • Nakagawa, Satoshi;
    • Fujimoto, Etsuko;
    • Tsuruta, Tomohiko;
    • Matsumoto, Harunobu;
    • Arakawa, Atsushi;
    • Nonaka, Michiko
    Publication type:
    Article
    48
    49
    50